The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 01, 2026
Snapshot (as of Sep 01, 2026): Becton, Dickinson and Company (BDX) pays a $3.74 annual dividend ($1.05 quarterly), yielding 1.99% at $187.90/share. Next ex-dividend date 2026-09-09. 26 consecutive years of dividend growth (Dividend Aristocrat). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.99%
Annual Dividend: $3.74 per share
Payout Ratio: 187.1% (based on depressed trailing earnings — see safety analysis below)
Ex-Dividend Date: 2026-09-09
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 45
Becton, Dickinson and Company dividend investors are looking at a global medical technology company that makes everything from IV catheters and insulin pen needles to diagnostic lab systems and surgical instruments. BDX currently yields 1.97%, with a trailing annual dividend rate of $3.7428 per share paid quarterly, and the next ex-dividend date falls on September 9, 2026. A Dividend Aristocrat with 26 consecutive years of increases, BDX appeals to investors who prioritize long-term dividend growth over immediate income. With a beta of 0.258, the stock moves far less than the broader market, which suits investors who value low price volatility alongside that growth.
Becton, Dickinson and Company pays out 187.1% of earnings as dividends, a payout ratio classified as high (above 75%). Becton, Dickinson and Company dividend safety rests on the breadth of its product portfolio: IV access systems, medication dispensing platforms, and diagnostic automation serve healthcare providers and clinical institutions with recurring, non-discretionary demand. That said, a payout ratio above 100% means current earnings do not fully cover the dividend, which is the most significant data-supported pressure point on the payout.
Over the past 14 years, Becton, Dickinson and Company dividend history shows a CAGR of 6.7% per year from 2011 to 2025. The per-share dividend grew from $1.68 to $4.17 over that window (2026 data is partial and excluded from the rate calculation). The smallest annual increase in the window was 2.6% in 2019, while the largest reached 10.2% in 2016.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +5.8% | $3.52 (2022) | $4.17 (2025) |
| 5-Year | +5.4% | $3.20 (2020) | $4.17 (2025) |
| 10-Year | +5.4% | $2.46 (2015) | $4.17 (2025) |
BDX fits dividend investors who want a long, unbroken growth record from a medical technology company with global reach, and who can accept a low current yield in exchange for that consistency. The yield sits at 1.97%, classified as low (below 2%), and it tracks almost exactly with the 5-year average of 1.96%, so there is no meaningful valuation discount on offer through yield alone. Twenty-six consecutive years of increases earns BDX its Dividend Aristocrat status, a streak built across IV delivery systems, lab diagnostics, and surgical products that serve essential healthcare functions. The trade-off is clear: the payout ratio of 187.1% is elevated, and the yield is modest. What an investor gets is a long, unbroken growth streak. What they give up is income.
BDX is a Dividend Aristocrat with 26 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-09 | $1.0500 |
| 2026-06-09 | $1.0500 |
| 2026-03-10 | $1.0500 |
| 2025-12-08 | $1.0500 |
| 2025-09-08 | $1.0400 |
| 2025-06-09 | $1.0400 |
| 2025-03-10 | $1.0400 |
| 2024-12-09 | $1.0400 |
| 2024-09-09 | $0.9500 |
| 2024-06-10 | $0.9500 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.1500 |
| 2025 | $4.1700 |
| 2024 | $3.8900 |
| 2023 | $3.6800 |
| 2022 | $3.5200 |
Project income from BDX with the BDX dividend calculator or track your full portfolio with the dividend tracker.